Satoshi Watanabe
Niigata University Medical and Dental Hospital · 436 works · 9,303 citations · h-index 41
Top works
- Alectinib versus crizotinib in patients with ALK -positive non-small-cell lung cancer (J-ALEX): an open-label, randomised phase 3 trial
- Rice plants take up iron as an Fe 3+ ‐phytosiderophore and as Fe 2+
- Erlotinib plus bevacizumab versus erlotinib alone in patients with EGFR-positive advanced non-squamous non-small-cell lung cancer (NEJ026): interim analysis of an open-label, randomised, multicentre, phase 3 trial
- Ramucirumab plus erlotinib in patients with untreated, EGFR-mutated, advanced non-small-cell lung cancer (RELAY): a randomised, double-blind, placebo-controlled, phase 3 trial
- Clinical responses to EGFR-tyrosine kinase inhibitor retreatment in non-small cell lung cancer patients who benefited from prior effective gefitinib therapy: a retrospective analysis
- Effectiveness of Gefitinib against Non–Small-Cell Lung Cancer with the Uncommon EGFR Mutations G719X and L861Q
- Biosynthesis and secretion of mugineic acid family phytosiderophores in zinc‐deficient barley
- Mutational reconstructed ferric chelate reductase confers enhanced tolerance in rice to iron deficiency in calcareous soil
- AXL confers intrinsic resistance to osimertinib and advances the emergence of tolerant cells
- Incidence and outcome of osteoporotic fractures in 2004 in Sado City, Niigata Prefecture, Japan
- Deoxymugineic acid increases Zn translocation in Zn-deficient rice plants
- Tumor-Induced CD11b+Gr-1+ Myeloid Cells Suppress T Cell Sensitization in Tumor-Draining Lymph Nodes
- Vitamin D and intact PTH status in patients with hip fracture
- Real Time Visualization of 13N-Translocation in Rice under Different Environmental Conditions Using Positron Emitting Tracer Imaging System
- 52Fe Translocation in Barley as Monitored by a Positron-Emitting Tracer Imaging System (PETIS): Evidence for the Direct Translocation of Fe from Roots to Young Leaves via Phloem
- Alectinib (ALC) versus crizotinib (CRZ) in ALK-inhibitor naive ALK-positive non-small cell lung cancer (ALK+ NSCLC): Primary results from the J-ALEX study.
- Final progression-free survival results from the J-ALEX study of alectinib versus crizotinib in ALK-positive non-small-cell lung cancer
- Expert system for blast furnace operation at Kimitsu works.
- Clinical Significance of Interferon-γ Neutralizing Autoantibodies Against Disseminated Nontuberculous Mycobacterial Disease
- Antioxidative Collagen-Derived Peptides In Human-Placenta Extract